The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le Roy, D.
Right arrow Articles by Heumann, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le Roy, D.
Right arrow Articles by Heumann, D.
The Journal of Immunology, 2001, 167: 2759-2765.
Copyright © 2001 by The American Association of Immunologists

Critical Role of Lipopolysaccharide-Binding Protein and CD14 in Immune Responses against Gram-Negative Bacteria1

Didier Le Roy*, Franco Di Padova{dagger}, Yoshiyuki Adachi{ddagger}, Michel Pierre Glauser*, Thierry Calandra* and Didier Heumann2,*

* Division of Infectious Diseases, Centre Hospitalier Universitaire Vaudois-Lausanne, Lausanne, Switzerland; {dagger} Pharma Research, Novartis, Basel, Switzerland; and {ddagger} Laboratory of Immunopharmacology of Microbial Products, Tokyo University of Pharmacy and Life Science, Tokyo, Japan

LPS-binding protein (LBP) and CD14 potentiate cell activation by LPS, contributing to lethal endotoxemia. We analyzed the contribution of LBP/CD14 in models of bacterial infection. Mice pretreated with mAbs neutralizing CD14 or LBP showed a delay in TNF-{alpha} production and died of overwhelming infection within 24 h, after a challenge with 250 CFU of virulent Klebsiella pneumoniae. Blockade of TNF-{alpha} also increased lethality, whereas pretreatment with TNF-{alpha} protected mice, even in the presence of LBP and CD14 blockade. Anti-LBP or anti-CD14 mAbs did not improve or decrease lethality with a higher inoculum (105 K. pneumoniae) and did not affect outcome following injections of low or high inocula of Escherichia coli O111. These results point to the essential role of LBP/CD14 in innate immunity against virulent bacteria.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Roger, C. Froidevaux, D. Le Roy, M. K. Reymond, A.-L. Chanson, D. Mauri, K. Burns, B. M. Riederer, S. Akira, and T. Calandra
Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4
PNAS, February 17, 2009; 106(7): 2348 - 2352.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. W. Chien, M. J. Boeckh, J. A. Hansen, and J. G. Clark
Lipopolysaccharide binding protein promoter variants influence the risk for Gram-negative bacteremia and mortality after allogeneic hematopoietic cell transplantation
Blood, February 15, 2008; 111(4): 2462 - 2469.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. C. Dessing, S. Knapp, S. Florquin, A. F. de Vos, and T. van der Poll
CD14 Facilitates Invasive Respiratory Tract Infection by Streptococcus pneumoniae
Am. J. Respir. Crit. Care Med., March 15, 2007; 175(6): 604 - 611.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Knapp, U. Matt, N. Leitinger, and T. van der Poll
Oxidized Phospholipids Inhibit Phagocytosis and Impair Outcome in Gram-Negative Sepsis In Vivo
J. Immunol., January 15, 2007; 178(2): 993 - 1001.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Echchannaoui, K. Frei, M. Letiembre, R. M. Strieter, Y. Adachi, and R. Landmann
CD14 deficiency leads to increased MIP-2 production, CXCR2 expression, neutrophil transmigration, and early death in pneumococcal infection
J. Leukoc. Biol., September 1, 2005; 78(3): 705 - 715.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
R. S. Munford
Invited review: Detoxifying endotoxin: time, place and person
Innate Immunity, April 1, 2005; 11(2): 69 - 84.
[Abstract] [PDF]


Home page
Infect. Immun.Home page
L. Hamann, C. Alexander, C. Stamme, U. Zahringer, and R. R. Schumann
Acute-Phase Concentrations of Lipopolysaccharide (LPS)-Binding Protein Inhibit Innate Immune Cell Activation by Different LPS Chemotypes via Different Mechanisms
Infect. Immun., January 1, 2005; 73(1): 193 - 200.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. Branger, S. Florquin, S. Knapp, J. C. Leemans, J. M. Pater, P. Speelman, D. T. Golenbock, and T. van der Poll
LPS-binding protein-deficient mice have an impaired defense against Gram-negative but not Gram-positive pneumonia
Int. Immunol., November 1, 2004; 16(11): 1605 - 1611.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
D. D. Bannerman, M. J. Paape, W. R. Hare, and J. C. Hope
Characterization of the Bovine Innate Immune Response to Intramammary Infection with Klebsiella pneumoniae
J Dairy Sci, August 1, 2004; 87(8): 2420 - 2432.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Cetin, H. R. Ford, L. R. Sysko, C. Agarwal, J. Wang, M. D. Neal, C. Baty, G. Apodaca, and D. J. Hackam
Endotoxin Inhibits Intestinal Epithelial Restitution through Activation of Rho-GTPase and Increased Focal Adhesions
J. Biol. Chem., June 4, 2004; 279(23): 24592 - 24600.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
D. D. Bannerman, M. J. Paape, J.-W. Lee, X. Zhao, J. C. Hope, and P. Rainard
Escherichia coli and Staphylococcus aureus Elicit Differential Innate Immune Responses following Intramammary Infection
Clin. Vaccine Immunol., May 1, 2004; 11(3): 463 - 472.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
D. Heumann, R. Lauener, and B. Ryffel
The dual role of LBP and CD14 in response to Gram-negative bacteria or Gram-negative compounds
Innate Immunity, December 1, 2003; 9(6): 381 - 384.
[Abstract] [PDF]


Home page
Infect. Immun.Home page
S. Knapp, A. F. de Vos, S. Florquin, D. T. Golenbock, and T. van der Poll
Lipopolysaccharide Binding Protein Is an Essential Component of the Innate Immune Response to Escherichia coli Peritonitis in Mice
Infect. Immun., December 1, 2003; 71(12): 6747 - 6753.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
D. D. Bannerman, M. J. Paape, W. R. Hare, and E. J. Sohn
Increased Levels of LPS-Binding Protein in Bovine Blood and Milk Following Bacterial Lipopolysaccharide Challenge
J Dairy Sci, October 1, 2003; 86(10): 3128 - 3137.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Ying, H. Suzuki, H. Furumoto, R. Walker, P. Meltzer, M. C. Willingham, and S.-Y. Cheng
Alterations in genomic profiles during tumor progression in a mouse model of follicular thyroid carcinoma
Carcinogenesis, September 1, 2003; 24(9): 1467 - 1479.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. Tasaka, A. Ishizaka, W. Yamada, M. Shimizu, H. Koh, N. Hasegawa, Y. Adachi, and K. Yamaguchi
Effect of CD14 Blockade on Endotoxin-Induced Acute Lung Injury in Mice
Am. J. Respir. Cell Mol. Biol., August 1, 2003; 29(2): 252 - 258.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
A J Kvalsvig and D J Unsworth
The immunopathogenesis of meningococcal disease
J. Clin. Pathol., June 1, 2003; 56(6): 417 - 422.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
D. Heumann
CD14 and LBP in endotoxemia and infections caused by Gram-negative bacteria
Innate Immunity, December 1, 2001; 7(6): 439 - 441.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.